Study of blood letting using leech application in the patients suffering from keloid.

A randomized controlled clinical trial of Jalaukavacharana[hirudotherapy]on vrangranthi w.s.r. to keloids

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023674

Enrollment

Registered

2020-03-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: jalaukavcharan: Application of 1 jalauka per 2 running centimeters of keloid after every 5 days for 8 weeks Control Intervention1: Inj triamcinolone and Inj Lignocaine: Inj triamcinolon

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of keloids irrespective of age, sex size, and site. Patients willing to participate and have given a writen consent for the same

Exclusion criteria

Exclusion criteria: Uncontrolled D.M. ï?? Seropositive patients- HIV, HbsAg ï?? Patients having deranged coagulation profile ï?? Patients taking antiplatelet drugs ï?? Infection of or near the keloid.

Design outcomes

Primary

Measure	Time frame
Relief in keloid using DLQI and POSAS scaleTimepoint: 8 weeks	—

Secondary

Measure	Time frame
arresting the local spread of keloidTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactDr Vinay R Sonambekar

Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik Maharashtra

sonambekar.chinmay@gmail.com9822624890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026